Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progressive International Holding (PIH) is a leading Egyptian healthcare conglomerate that provides integrated solutions across the pharmaceutical and medical sectors. Established in 1994, the company operates through several specialized subsidiaries involved in pharmaceutical manufacturing, medical device distribution, and diagnostic services. PIH serves as a critical bridge for multinational healthcare companies seeking to enter or expand within the Middle East and North Africa (MENA) markets. The group's manufacturing arm, Progressive Pharma, produces a variety of generic medications, while its distribution units represent global leaders in medical technology. PIH is headquartered in Cairo and maintains a robust logistics network to support its extensive commercial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progressive International Holding Company.